NCT06759961 Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant Centre
| NCT ID | NCT06759961 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Microangiopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2033-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2023-02-01 with a primary completion date of 2033-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is a retrospective-prospective, single-centre, non-pharmacological, retrospective tissue study carried out for scientific and health protection purposes. It involves the systematic collection of clinical information from patients diagnosed with PT-TMA
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Living kidney transplant recipient, brain death cadaver donor, cardiac death cadaver donor, single kidney transplant, double kidney transplant, combined kidney transplant * Acquisition of Informed Consent to participate in the study and to process personal, special and genetic data Exclusion Criteria: \-
Contact & Investigator
Giorgia Comai, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06759961 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Microangiopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06759961 currently recruiting?
Yes, NCT06759961 is actively recruiting participants. Contact the research team at marcello.demetri2@unibo.it for enrollment information.
Where is the NCT06759961 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06759961 clinical trial?
NCT06759961 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Giorgia Comai, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 250 participants.